ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,109.07
0.89%
Dow Jones
38,561.82
0.88%
US Dollar vs MXN
16.98026
0.05%
Brent Oil
83.16
-0.56%
Bitcoin
61,655.57
4.29%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Relay Therapeutics Inc (RLAY)

  7. Relay Therapeutics Inc (RLAY) Noticias

RLAY Relay Therapeutics Inc

6.98
-0.10 (-1.41%)
Última actualización: 09:42:21
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Relay Therapeutics Inc RLAY NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.10 -1.41% 6.98 09:42:21
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.71 6.965 8.71 7.08
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:05GLOBERelay Therapeutics Reports First Quarter 2024 Financial..
25/4/202415:05GLOBERelay Therapeutics to Announce First Quarter 2024 Financial..
11/4/202415:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
26/2/202415:05GLOBERelay Therapeutics to Participate in Three Upcoming Investor..
22/2/202415:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202415:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202415:10EDGAR2Form 8-K - Current report
22/2/202415:05GLOBERelay Therapeutics Reports Fourth Quarter and Full Year 2023..
15/2/202415:05GLOBERelay Therapeutics to Announce Fourth Quarter and Full Year..
01/2/202415:05GLOBERelay Therapeutics to Participate in the Guggenheim..
31/1/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
10/1/202408:14EDGAR2Form D - Notice of Exempt Offering of Securities
08/1/202406:05EDGAR2Form 8-K - Current report
08/1/202406:00GLOBERelay Therapeutics Announces $30 Million Private Placement..
02/1/202415:05GLOBERelay Therapeutics to Present at 42nd Annual J.P. Morgan..
29/12/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:16EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
07/11/202315:05GLOBERelay Therapeutics to Participate in Stifel 2023 Healthcare..
02/11/202315:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:10EDGAR2Form 8-K - Current report
02/11/202315:05GLOBERelay Therapeutics Reports Third Quarter 2023 Financial..
01/11/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202315:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:05GLOBERelay Therapeutics to Announce Third Quarter 2023 Financial..
12/10/202315:13EDGAR2Form 8-K - Current report
12/10/202315:05GLOBERelay Therapeutics Announces Initial RLY-4008..
29/9/202316:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202315:05GLOBERelay Therapeutics to Present Clinical Data on RLY-4008 in..
08/8/202315:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:14EDGAR2Form 8-K - Current report
08/8/202315:02GLOBERelay Therapeutics Reports Second Quarter 2023 Financial..
01/8/202315:05GLOBERelay Therapeutics to Announce Second Quarter 2023 Financial..
31/7/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202316:01GLOBERelay Therapeutics Announces Full Dose Escalation Data for..
24/5/202315:05GLOBERelay Therapeutics to Participate in Two Upcoming Investor..
04/5/202315:05GLOBERelay Therapeutics Reports First Quarter 2023 Financial..

Su Consulta Reciente

NASDAQ
RLAY
Relay Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados